External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology ILC 2026
Roche and Genentech at

ILC 2026

September 23 - September 26
San Francisco, USA
ilcsymposium.com
We will be contributing to topics related to
Oncology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
12:30 AM
Duration 120mins San Francisco, USA
Efficacy and safety of giredestrant (GIRE) in patients (pts) with estrogen receptor-positive, HER2-negative early breast cancer (ER+, HER2– eBC) in the Phase III lidERA BC clinical trial: Results by menopausal status (encore submission)
Peter Schmid, Charles E. Geyer, Jr., Miguel Martín, Sara A. Hurvitz, Kyung Hae Jung, Mothaffar F. Rimawi, Shigehira Saji, Gustavo Werutsky, Nadia Harbeck, Sherene Loi, Ernesto Pablo Korbenfeld, Isabel Blancas, Chi-Feng Chung, Rena Desai Callahan, Meilin Huang, Miranda Craft, Mona D. Shah, Tanja Badovinac Crnjevic, Pablo Diego Pérez-Moreno, Aditya Bardia
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins San Francisco, USA
Outcomes by lobular (lob) histology status at initial diagnosis in patients (pts) in the INAVO120 Phase 3 trial with PIK3CA-mutated (mut), hormone receptor-positive (HR+), HER2-negative (HER2–), endocrine-resistant advanced breast cancer (aBC) treated with inavolisib▼ (INAVO)/placebo (PBO) + palbociclib (PALBO) + fulvestrant (FULV)
Nicholas Turner, Kevin M. Kalinsky, Katherine E. Hutchinson, Yanling Jin, Tiffany D. Clark, Komal L. Jhaveri, Sibylle Loibl, Cristina Saura, Christine Desmedt, Hans Wildiers, Seock-Ah Im, Patrick Neven, Peter Schmid, Dejan Juric, Sherene Loi, Stephanie Hilz, Thomas J. Stout
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.